Background Psoriasis has been linked to an increased risk of metabolic syndrome (MetS).
Non‐alcoholic fatty liver disease (NAFLD), the hepatic manifestation of MetS, is now the …

Purpose Chronic plaque psoriasis is associated with the presence of non-alcoholic fatty liver
disease (NAFLD), but the magnitude of this association remains currently uncertain. We …

Background Recent case-control studies observed an increased prevalence of nonalcoholic
fatty liver disease (NAFLD) in patients with psoriasis, which is relevant in selecting optimal …

BACKGROUND/AIMS: The association between NAFLD and psoriasis has never been
explored in prospective epidemiological studies. The aim of this 2-phase study was to study …

Psoriasis is a chronic inflammatory immune-mediated skin diseases which is frequently
associated to comorbidities. Non-alcoholic fatty liver disease (NAFLD) is defined as an …

Background Psoriasis is a chronic, immune‐mediated inflammatory skin disease with many
extracutaneous manifestations. Several recent studies have indicated an increased …

Background Association between nonalcoholic fatty liver disease (NAFLD) and future
psoriasis has not yet been confirmed, although the two diseases partially share a common …

Background: Psoriasis is an inflammatory disease of the skin and joints. Previous studies
have shown a higher prevalence of metabolic syndrome (MS) in psoriatic patients. Recent …

Importance Recent studies have shown an association between psoriasis and nonalcoholic
fatty liver disease (NAFLD) in US inpatients, but the association is still unclear in the …

Background Patients with psoriasis are at risk of non‐alcoholic fatty liver disease (NAFLD)
and likely liver fibrosis. Objective Investigate the prevalence of NAFLD in patients with …